New Key Statistics Module, Z-Score and F-Score
NAS:AVDL Key Ratios
| Market Cap $ M | 1,197.61 |
| Enterprise Value $ M | 1,151.50 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 18.22 |
| Price/Book | 17.04 |
| Price/Sales | 12.17 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 95.00 |
| EPS (TTM) $ | -1.14 |
| Beneish M-Score | 53.11 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.87 |
| EV-to-EBITDA | -12.07 |
| PEG | -- |
| Shares Outstanding M | 96.27 |
| Net Margin (%) | -111.64 |
| Operating Margin % | -103.82 |
| Pre-tax Margin (%) | -112.09 |
| Quick Ratio | 2.52 |
| Current Ratio | 2.82 |
| ROA % (ttm) | -59.40 |
| ROE % (ttm) | -108.45 |
| ROIC % (ttm) | -187.92 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.59 |
AVDL Number of Guru Trades
AVDL Volume of Guru Trades
Gurus Latest Trades with NAS:AVDL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AVDL is held by these investors
Total 1
Avadel Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:AVDL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers